Evermay Wealth Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-24
Closed -$2.44K 604
2025
Q4
$2.44K Sell
24
-26
-52% -$2.09K ﹤0.01% 507
2025
Q3
$2.74K Hold
50
﹤0.01% 487
2025
Q2
$2.66K Hold
50
﹤0.01% 493
2025
Q1
$2.17K Hold
50
﹤0.01% 514
2024
Q4
$2.81K Hold
50
﹤0.01% 505
2024
Q3
$3.41K Hold
50
﹤0.01% 523
2024
Q2
$2.11K Hold
50
﹤0.01% 542
2024
Q1
$3.45K Hold
50
﹤0.01% 514
2023
Q4
$3.7K Hold
50
﹤0.01% 493
2023
Q3
$3.41K Hold
50
﹤0.01% 482
2023
Q2
$4.7K Hold
50
﹤0.01% 465
2023
Q1
$3.39K Hold
50
﹤0.01% 471
2022
Q4
$2.48K Buy
+50
New +$2.04K ﹤0.01% 486

Other funds holding EXAS

Evermay Wealth Management's EXAS Position: Q1 2026 in Review

Evermay Wealth Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 24 shares — an estimated $2.44K sold.

Evermay Wealth Management first reported a position in EXAS in Q4 2022 and held it in 13 quarters. The position peaked at $4.7K in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Evermay Wealth Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Evermay Wealth Management sold 24 Exact Sciences shares in Q1 2026, an estimated $2.44K.
  • Evermay Wealth Management first reported a position in Exact Sciences in Q4 2022 and held it in 13 quarters.
  • Evermay Wealth Management's Exact Sciences position peaked at $4.7K in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Evermay Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.